182 related articles for article (PubMed ID: 16098147)
1. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Nakagawa K; Kuzumaki N
Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
[TBL] [Abstract][Full Text] [Related]
2. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
3. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
4. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
5. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
7. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
8. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
9. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
10. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Tian S; Poukka H; Palvimo JJ; Jänne OA
Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
[TBL] [Abstract][Full Text] [Related]
11. Serum response factor is modulated by the SUMO-1 conjugation system.
Matsuzaki K; Minami T; Tojo M; Honda Y; Uchimura Y; Saitoh H; Yasuda H; Nagahiro S; Saya H; Nakao M
Biochem Biophys Res Commun; 2003 Jun; 306(1):32-8. PubMed ID: 12788062
[TBL] [Abstract][Full Text] [Related]
12. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
13. Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity.
Kalita K; Kharebava G; Zheng JJ; Hetman M
J Neurosci; 2006 Sep; 26(39):10020-32. PubMed ID: 17005865
[TBL] [Abstract][Full Text] [Related]
14. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.
Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH
Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624
[TBL] [Abstract][Full Text] [Related]
15. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
16. SUMO represses transcriptional activity of the Drosophila SoxNeuro and human Sox3 central nervous system-specific transcription factors.
Savare J; Bonneaud N; Girard F
Mol Biol Cell; 2005 Jun; 16(6):2660-9. PubMed ID: 15788563
[TBL] [Abstract][Full Text] [Related]
17. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
18. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
Kang SI; Chang WJ; Cho SG; Kim IY
J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
[TBL] [Abstract][Full Text] [Related]
20. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]